OXYMORPHONE HCL ER 7.5 MG TAB

Oxymorphone hydrochloride
$3.1804per EA
DEA Schedule CII

Strength

7.5 mg/1

NDC

00115131501

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

3/18/2020

Active Ingredients

OXYMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079087

On Market Since

1/2/2013

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+58.3%